NDC 50742-639 – Quetiapine Fumarate
Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · Oral
Product NDC50742-639
Product details
- Brand name
- Quetiapine Fumarate
- Generic name
- quetiapine fumarate
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA208947
- Marketed since
- August 31, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Quetiapine Fumarate 400 mg/1
Uses, dosage, side effects and warnings for Quetiapine Fumarate →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 50742-639-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-639-10) | Aug 31, 2017 |
| 50742-639-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-639-30) | Aug 31, 2017 |
| 50742-639-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-639-60) | Aug 31, 2017 |
| 50742-639-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-639-90) | Aug 31, 2017 |
Other Quetiapine Fumarate products
- 68788-8764 Quetiapine Fumarate 25 mg/1 · Tablet · : Preferred Pharmaceuticals Inc.
- 50090-5884 Quetiapine Fumarate 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-3342 Quetiapine Fumarate 50 mg/1 · Tablet · A-S Medication Solutions
- 50090-6812 Quetiapine Fumarate 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-5473 Quetiapine Fumarate 400 mg/1 · Tablet · A-S Medication Solutions
- 50090-3983 Quetiapine Fumarate 300 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-6337 Quetiapine Fumarate 400 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-3377 Quetiapine Fumarate 100 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-3333 Quetiapine Fumarate 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-7471 Quetiapine Fumarate 200 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 16729-132 Quetiapine Fumarate 50 mg/1 · Tablet, Extended Release · Accord Healthcare Inc.
- 16729-096 Quetiapine Fumarate 300 mg/1 · Tablet, Extended Release · Accord Healthcare Inc.